| scholarly article | Q13442814 |
| P50 | author | Denis Servent | Q46913748 |
| Evelyne Benoit | Q87759389 | ||
| P2093 | author name string | Michael Kurz | |
| Gerhard Hessler | |||
| Michel De Waard | |||
| Laurent Bialy | |||
| Laetitia Lucarain | |||
| Jean-Marie Chambard | |||
| Brigitte Schombert | |||
| Michel Partiseti | |||
| Tânia C Gonçalves | |||
| Rémy Béroud | |||
| Andrees Bohme | |||
| Stéphanie Combemale | |||
| Lucie Jaquillard | |||
| Rachid Boukaiba | |||
| Sophie Fouconnier | |||
| Stéphane Hourcade | |||
| P2860 | cites work | Sodium Channels and Venom Peptide Pharmacology. | Q39320577 |
| Analgesic Effects of GpTx-1, PF-04856264 and CNV1014802 in a Mouse Model of NaV1.7-Mediated Pain. | Q39587472 | ||
| Single Residue Substitutions That Confer Voltage-Gated Sodium Ion Channel Subtype Selectivity in the NaV1.7 Inhibitory Peptide GpTx-1. | Q39987073 | ||
| Lengths of the C-Terminus and Interconnecting Loops Impact Stability of Spider-Derived Gating Modifier Toxins | Q41569702 | ||
| THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Voltage-gated ion channels. | Q42660441 | ||
| Mapping the interaction site for the tarantula toxin hainantoxin-IV (β-TRTX-Hn2a) in the voltage sensor module of domain II of voltage-gated sodium channels | Q44650001 | ||
| Structure--activity relationships of hainantoxin-IV and structure determination of active and inactive sodium channel blockers | Q44939687 | ||
| Sex differences in pain and pain inhibition: multiple explanations of a controversial phenomenon | Q45169984 | ||
| Isolation, synthesis and characterization of ω-TRTX-Cc1a, a novel tarantula venom peptide that selectively targets L-type Cav channels | Q45812042 | ||
| The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY. | Q47139831 | ||
| Modulatory features of the novel spider toxin μ-TRTX-Df1a isolated from the venom of the spider Davus fasciatus. | Q48100659 | ||
| Sodium channels and pain: from toxins to therapies | Q48337085 | ||
| Direct evidence for high affinity blockade of NaV1.6 channel subtype by huwentoxin-IV spider peptide, using multiscale functional approaches. | Q52688201 | ||
| Intrathecal miR-96 inhibits Nav1.3 expression and alleviates neuropathic pain in rat following chronic construction injury | Q54351607 | ||
| Pharmacological characterization of potent and selective NaV1.7 inhibitors engineered from Chilobrachys jingzhao tarantula venom peptide JzTx-V. | Q55037976 | ||
| The Na1.7 Channel Subtype as an Antinociceptive Target for Spider Toxins in Adult Dorsal Root Ganglia Neurons | Q58764681 | ||
| Dexamethasone influence on morphine-induced analgesia in outbred Swiss and inbred DBA/2J and C57BL/6 mice | Q72748591 | ||
| Effects of membrane polarization and ischaemia on the excitability properties of human motor axons | Q73251210 | ||
| A positively charged surface patch is important for hainantoxin-IV binding to voltage-gated sodium channels | Q84882964 | ||
| An evaluation of 30 clinical drugs against the comprehensive in vitro proarrhythmia assay (CiPA) proposed ion channel panel | Q89149614 | ||
| Involvement of Voltage-Gated Calcium Channels in Inflammation and Inflammatory Pain | Q90698388 | ||
| Sodium channel Na(v)1.6 is localized at nodes of ranvier, dendrites, and synapses | Q24653551 | ||
| Function and solution structure of huwentoxin-IV, a potent neuronal tetrodotoxin (TTX)-sensitive sodium channel antagonist from Chinese bird spider Selenocosmia huwena | Q27639643 | ||
| Analysis of the Structural and Molecular Basis of Voltage-sensitive Sodium Channel Inhibition by the Spider Toxin Huwentoxin-IV ( -TRTX-Hh2a) | Q27678595 | ||
| Identification and Characterization of ProTx-III [μ-TRTX-Tp1a], a New Voltage-Gated Sodium Channel Inhibitor from Venom of the Tarantula Thrixopelma pruriens | Q27700858 | ||
| Rational Engineering Defines a Molecular Switch That Is Essential for Activity of Spider-Venom Peptides against the Analgesics Target NaV1.7 | Q27702229 | ||
| International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels | Q28289125 | ||
| Global Nav1.7 knockout mice recapitulate the phenotype of human congenital indifference to pain | Q28542818 | ||
| Selective spider toxins reveal a role for the Nav1.1 channel in mechanical pain | Q28594552 | ||
| Isolation and characterization of hainantoxin-IV, a novel antagonist of tetrodotoxin-sensitive sodium channels from the Chinese bird spider Selenocosmia hainana | Q30807017 | ||
| Insensitivity to pain induced by a potent selective closed-state Nav1.7 inhibitor | Q33390819 | ||
| Tetrodotoxin for Moderate to Severe Cancer-Related Pain: A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Design Trial | Q33710457 | ||
| Animal research: reporting in vivo experiments: the ARRIVE guidelines | Q34116755 | ||
| The Tarantula Toxins ProTx-II and Huwentoxin-IV Differentially Interact with Human Nav1.7 Voltage Sensors to Inhibit Channel Activation and Inactivation | Q34359543 | ||
| Engineering potent and selective analogues of GpTx-1, a tarantula venom peptide antagonist of the Na(V)1.7 sodium channel | Q34461603 | ||
| Spider-venom peptides as therapeutics. | Q35155666 | ||
| Pathophysiological implication of CaV3.1 T-type Ca2+ channels in trigeminal neuropathic pain | Q36646432 | ||
| Multiple sodium channels and their roles in electrogenesis within dorsal root ganglion neurons | Q36678533 | ||
| Tarantula huwentoxin-IV inhibits neuronal sodium channels by binding to receptor site 4 and trapping the domain ii voltage sensor in the closed configuration | Q36914467 | ||
| Structure and Function of Hainantoxin-III, a Selective Antagonist of Neuronal Tetrodotoxin-sensitive Voltage-gated Sodium Channels Isolated from the Chinese Bird Spider Ornithoctonus hainana | Q37012447 | ||
| Engineering Highly Potent and Selective Microproteins against Nav1.7 Sodium Channel for Treatment of Pain | Q37065681 | ||
| Assessment of nerve excitability in toxic and metabolic neuropathies | Q37111987 | ||
| Spider-venom peptides that target voltage-gated sodium channels: pharmacological tools and potential therapeutic leads. | Q38006317 | ||
| The Na(V)1.7 sodium channel: from molecule to man. | Q38066723 | ||
| Regulating excitability of peripheral afferents: emerging ion channel targets | Q38182826 | ||
| Painful and painless channelopathies. | Q38210568 | ||
| Voltage-Gated Sodium Channels: Structure, Function, Pharmacology, and Clinical Indications | Q38451134 | ||
| Niclosamide Inhibits Oxaliplatin Neurotoxicity while Improving Colorectal Cancer Therapeutic Response | Q38726030 | ||
| NaV1.7 as a pain target - From gene to pharmacology. | Q39029029 | ||
| P433 | issue | 9 | |
| P304 | page(s) | 1298-1314 | |
| P577 | publication date | 2019-04-09 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | From identification to functional characterization of cyriotoxin-1a, an antinociceptive toxin from the spider Cyriopagopus schioedtei | |
| P478 | volume | 176 |
Search more.